Add Company
Join Now

Rénibus Therapeutics Revenue and Competitors

License our Company Data API

Location

#1885

Growjo Ranking

Pharma

Industry
Embed

Estimated Revenue & Valuation

  • Rénibus Therapeutics's estimated annual revenue is currently $3.8M per year.(i)
  • Rénibus Therapeutics's estimated revenue per employee is $100,500

Employee Data

  • Rénibus Therapeutics has 38 Employees.(i)
  • Rénibus Therapeutics grew their employee count by 27% last year.

Rénibus Therapeutics's People

NameTitleEmail/Phone
1
VP Regulatory AffairsReveal Email/Phone
2
VP CommercialReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
SVP, Program Management, Technical Operations and ManufacturingReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Senior Medical Director, Clinical Development and Medical AffairsReveal Email/Phone
7
Co-CEOReveal Email/Phone
8
Financial ControllerReveal Email/Phone
9
Chairman the Board Directors RenibusReveal Email/Phone
10
Co-CEO, Co-FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.7M13320%N/AN/A
#2
$13.5M676%N/AN/A
#3
$16.1M80-2%N/AN/A
#4
$62.5M0N/AN/AN/A
#5
$10.1M506%N/AN/A
#6
$119.4M59427%N/AN/A
#7
$22.9M1148%N/AN/A
#8
$92.9M4628%N/AN/A
#9
$11.3M56-8%N/AN/A
#10
$7M356%N/AN/A
Add Company

What Is Rénibus Therapeutics?

Rénibus Therapeutics is a clinical-stage biotech company dedicated to transforming the cardiorenal disease treatment paradigm by focusing on the prevention and treatment of kidney disease. The company’s portfolio includes RBT-1 for prevention of acute kidney injury, RBT-2 for treatment of chronic kidney disease, and RBT-3 for treatment of iron deficiency anemia and platinum-based kidney toxicity.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$3.8M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.2M38N/AN/A
#2
$8.2M380%N/A
#3
$6.4M380%N/A
#4
$9.3M40-7%N/A
#5
N/A4111%N/A